Introduction: Patients with cardiogenic shock (CS) have high mortality. Many CS patients present to non-tertiary care centers. Limited data exist on outcomes for patients transferred to “hub” CS ...
Multidisciplinary Shock Teams have improved clinical outcomes for cardiogenic shock, but their implementation costs have not been studied. This study’s objective was to compare costs between patients ...
If it's hot or the patient has been exerting themselves, consider dehydration. When the heart has difficulty pumping blood adequately, it is known as cardiogenic shock. It can occur after a myocardial ...
Hospitals with lower risk-adjusted in-hospital mortality rates (RAMR) among patients with cardiogenic shock following acute myocardial infarction (AMI) demonstrated higher rates of revascularization ...
Within the prior 24 months, I have had a financial relationship with a company producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients: Receive the the ...
The istaroxime patent is entitled, “ISTAROXIME-CONTAINING INTRAVENOUS FORMULATION FOR THE TREATMENT OF PRE-CARDIOGEN1C SHOCK AND CARDIOGENIC SHOCK”, is No. PCT/US2023/018998 and was assigned ...